Dosage Regimen: Individualization
Therapeutic Drug Monitoring: Affecting Factors
Pulmonary Tuberculosis V
Pulmonary Tuberculosis IV
Pulmonary Tuberculosis I
Drug Therapy
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Hanif Esmail1, Marc C Lipman2, Andrew Nunn3
1Medical Research Council Clinical Trials Unit, University College London, London, UK; Institute for Global Health, University College London, London, UK; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
No abstract available in PubMed .